CLINICAL CHEMISTRY AST-ACTIVATED 8L91-21

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01 report with the FDA on 2011-06-06 for CLINICAL CHEMISTRY AST-ACTIVATED 8L91-21 manufactured by Abbott Manufacturing Inc.

Event Text Entries

[2007770] The customer stated that an architect activated ast result of <0. 08 u/l was generated on a female patient. The patient's activated alt result was 300 u/l. The activated ast result was repeated using a manual dilution which generated a very high result (exact value not provided). The customer suspects that substrate depletion occurred causing the initial result to be falsely low. The initial result was repeated because it did not align with the other laboratory results (elevated alt). During a follow-up conversation, the customer stated that the patient had died during surgery due to cardiac arrest. The initial low result was not reported out of the laboratory and there was no delay in treatment. The customer stated that the activated ast results did not cause or contribute to the patient death.
Patient Sequence No: 1, Text Type: D, B5


[8982532] (b)(4). An investigation is in process. A follow-up report will be submitted when the investigation is complete.
Patient Sequence No: 1, Text Type: N, H10


[9381026] The patient sample was available and was returned for investigation. Testing was also performed on the customer's returned patient serum sample with flex parameters. The patient sample did not generate a <5 u/l (<0. 08 ukat/l) result when run undiluted as observed by the customer. Undiluted and diluted 1:2 samples all gave either error code 1350 and 1351. When the sample was diluted 1:3, the result was >5364 u/l with a#2, >, and flex flags. Testing was performed to evaluate high activated aspartate aminotransferase (a-ast) concentration samples with flex read time and without flex read time. Samples were prepared using a serum pool and 4% human serum albumin (hsa). High samples were prepared in concentrations between ~20,000 u/l to ~200, and low samples were prepared in concentrations of ~100 to ~10. All serum pool and 4% hsa samples generated results within stated acceptance criteria. The serum pool and 4% hsa samples also generated results and/or flags appropriately based on the expected concentrations and no <5 u/l results were generated. A quality review of complaint activity for the a-ast assay was conducted and did not identify any adverse or non-statistical trends for patient results. The a-ast package insert was reviewed and was found to include information regarding dilutions exceeding linearity and flex rate linearity procedures. Based upon the data available and the results of the evaluation, no product deficiency was identified. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1628664-2011-00278
MDR Report Key2114735
Report Source01
Date Received2011-06-06
Date of Report2011-05-25
Date Mfgr Received2011-10-21
Device Manufacturer Date2010-11-19
Date Added to Maude2011-06-07
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactNOEMI ROMERO-KONDOS, RN BSN
Manufacturer Street100 ABBOTT PARK ROAD DEPT. 09B9, LCCP1-3
Manufacturer CityABBOTT PARK IL 600643537
Manufacturer CountryUS
Manufacturer Postal600643537
Manufacturer Phone8479375120
Manufacturer G1ABBOTT MANUFACTURING INC
Manufacturer Street1921 HURD DRIVE
Manufacturer CityIRVING TX 75038
Manufacturer CountryUS
Manufacturer Postal Code75038
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCLINICAL CHEMISTRY AST-ACTIVATED
Generic NameFOR THE QUANTITATION OF ASPARTATE AMINOTRANSFERASE IN HUMAN SERUM OR PLASMA
Product CodeCIT
Date Received2011-06-06
Catalog Number8L91-21
Lot Number65900UN10
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerABBOTT MANUFACTURING INC
Manufacturer Address1921 HURD DRIVE IRVING TX 75038 US 75038


Patients

Patient NumberTreatmentOutcomeDate
10 2011-06-06

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.